Clinical trial
Intensity Modulated Radiation Therapy for Head and Neck Cancer
NCT00188877 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188877 |
|---|---|
| Title | Intensity Modulated Radiation Therapy for Head and Neck Cancer |
| Official title | A Phase II Study of Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Neoplasms |
| Intervention type | Drug, Procedure |
| Interventions | intensity modulated radiation therapy, cisplatinium and fluorouracil - standard treatment |
| Enrollment | 44 |
| Start date | Jun 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2019 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 2, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: